Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm’s Japan defeat
Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm’s [...]
Fierce Pharma Asia—Samsung and Biogen rumors; Novartis-BeiGene TIGIT deal; Aduhelm’s [...]
Blueprint’s Ayvakit launch ramps up as it taps LabCorp, new [...]
Viatris shareholders rail against execs’ hefty pay packages fkansteiner Thu, [...]
Pfizer, Roche, AstraZeneca and J&J face newly revived lawsuit claiming [...]
AstraZeneca, Amgen tap Brand Institute in new naming twist for [...]
Pfizer carries pandemic momentum into 2022, scoring another huge Paxlovid [...]
Continuus Pharma to build $125M manufacturing site in Massachusetts jkeenan [...]
Novo Holdings buys sterile injectables maker Ritedose for undisclosed price [...]
Arcutis reups ahead of critical year for topical drug delivery [...]
Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug [...]